Recalls in May 2010

Toyota will notify owners when the recall begins during May 2010.

Owners may contact Toyota at 1-800-331-4331.

Consumers may contact the National Highway Traffic Safety Administration (NHTSA) at 1-888-327-4236 (TTY: 1-800-424-9153) or at www.safercar.gov.

Parents and caregivers are being alerted to a sweeping recall of infants' and children's Tylenol, Motrin, Zyrtec and Benadryl products. McNeil Consumer Healthcare, a unit of Johnson & Johnson, is recalling the over-the-counter medicine because of a manufacturing deficiency, according to the Food and Drug Administration.

The FDA said the manufacturing deficiency could affect the products' purity, potency and quality and could cause some batches to contain more of the active drug ingredient than specified.

In a statement on its Web site, the company said that no adverse medical events had been reported. A complete list of the recalled products appears below.

"We want to be certain that consumers discontinue using these products and that they know what to do if they have concerns about a specific product," said Commissioner of Food and Drugs Margaret A. Hamburg, M.D. "While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality. We are investigating the products and facilities associated with this recall and will provide updates as we learn more."

Some of the products included in the recall may contain a higher concentration of active ingredient than specified. Others contain inactive ingredients that may not meet internal testing requirements and others may contain tiny particles. While the potential for serious medical events is remote, FDA advises consumers who have purchased these recalled products to discontinue use.

Products listed

The FDA said there are a number of other products on the market, including generic versions of the recalled products, which are intended for use in infants and children and are not affected by the recall. FDA recommends that you check the labeling of these products. If you have any questions, you should discuss this with your pharmacist or other health care professional. FDA does not anticipate that there will be a shortage of alternative products.

One alternative that should not be considered, the FDA says, is substituting adult-strength versions of the recalled products. Consumers should not give drug products to infants and children that are not intended for those age groups. This could result in serious harm, the agency said.

Adverse reactions or quality problems experienced with the use of these products may be reported to FDA's MedWatch Adverse Event Reporting program either online, by regular mail, or by fax.

The agency asks health care professionals and consumers to report any adverse reactions to the FDA's MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website.